A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents

Compared to the general population, patients with multiple myeloma (MM) have a nine-fold increased risk of developing venous thromboembolism (VTE). Little is known about VTE prophylaxis in relapsed/refractory (RR) MM patients treated with next generation anti-myeloma drugs, such as pomalidomide (Pom...

Descripción completa

Detalles Bibliográficos
Autores principales: Calafiore, Valeria, Giamporcaro, Silvia, Conticello, Concetta, Romano, Alessandra, Parisi, Marina, Giuffrida, Gaetano, Tibullo, Daniele, Di Raimondo, Francesco, Signorelli, Salvatore Santo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563719/
https://www.ncbi.nlm.nih.gov/pubmed/32899553
http://dx.doi.org/10.3390/jcm9092876

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563719/
https://www.ncbi.nlm.nih.gov/pubmed/32899553
http://dx.doi.org/10.3390/jcm9092876

Ejemplares similares